ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.000
+0.080 (2.74%)
Jul 31, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.29 billion as of July 31, 2026. Its market cap has decreased by -72.36% in one year.
Market Cap
1.29B
Enterprise Value
416.18M
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
ChartMarket Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.29B, a decrease of -82.23%. That is a compound annual growth rate of -44.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.29B | -48.54% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.89B |
| AIM Vaccine | 1.77B |
| Mabpharm | 1.65B |
| HighTide Therapeutics | 1.49B |
| Zhaoke Ophthalmology | 1.36B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.29B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| CANbridge Pharmaceuticals | 1.18B |